- Home
- ASPN vs RCKT Comparison
ASPN vs RCKT Comparison
Compare ASPN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- RCKT
- Stock Information
- Founded
- ASPN 2001
- RCKT 1999
- Country
- ASPN United States
- RCKT United States
- Employees
- ASPN N/A
- RCKT N/A
- Industry
- ASPN RETAIL: Building Materials
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- RCKT Health Care
- Exchange
- ASPN Nasdaq
- RCKT Nasdaq
- Market Cap
- ASPN 486.5M
- RCKT 264.0M
- IPO Year
- ASPN 2014
- RCKT N/A
- Fundamental
- Price
- ASPN $6.65
- RCKT $3.00
- Analyst Decision
- ASPN Strong Buy
- RCKT Buy
- Analyst Count
- ASPN 10
- RCKT 13
- Target Price
- ASPN $21.78
- RCKT $18.50
- AVG Volume (30 Days)
- ASPN 1.5M
- RCKT 3.8M
- Earning Date
- ASPN 08-06-2025
- RCKT 08-04-2025
- Dividend Yield
- ASPN N/A
- RCKT N/A
- EPS Growth
- ASPN N/A
- RCKT N/A
- EPS
- ASPN N/A
- RCKT N/A
- Revenue
- ASPN $436,921,000.00
- RCKT N/A
- Revenue This Year
- ASPN N/A
- RCKT N/A
- Revenue Next Year
- ASPN $24.31
- RCKT N/A
- P/E Ratio
- ASPN N/A
- RCKT N/A
- Revenue Growth
- ASPN 51.90
- RCKT N/A
- 52 Week Low
- ASPN $4.16
- RCKT $2.19
- 52 Week High
- ASPN $33.15
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- ASPN 59.86
- RCKT 45.55
- Support Level
- ASPN $6.17
- RCKT $2.76
- Resistance Level
- ASPN $7.18
- RCKT $3.24
- Average True Range (ATR)
- ASPN 0.38
- RCKT 0.19
- MACD
- ASPN 0.10
- RCKT 0.17
- Stochastic Oscillator
- ASPN 78.96
- RCKT 74.85
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.